These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21973050)

  • 1. Special issue: engineering toxins for 21st-century therapies: introduction.
    Acharya KR
    FEBS J; 2011 Dec; 278(23):4453. PubMed ID: 21973050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering toxins for 21st century therapies.
    Chaddock JA; Acharya KR
    FEBS J; 2011 Apr; 278(6):899-904. PubMed ID: 21382174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein engineering for therapeutics, Part A. Preface.
    Wittrup KD; Verdine GL
    Methods Enzymol; 2012; 502():xiii-xiv. PubMed ID: 22208991
    [No Abstract]   [Full Text] [Related]  

  • 4. Natural toxins and their therapeutic potential.
    Kapoor VK
    Indian J Exp Biol; 2010 Mar; 48(3):228-37. PubMed ID: 21046975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplexed toxin analysis using four colors of quantum dot fluororeagents.
    Goldman ER; Clapp AR; Anderson GP; Uyeda HT; Mauro JM; Medintz IL; Mattoussi H
    Anal Chem; 2004 Feb; 76(3):684-8. PubMed ID: 14750863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic engineering in the 21st century: meeting global challenges of sustainability and health.
    Betenbaugh M; Bentley W
    Curr Opin Biotechnol; 2008 Oct; 19(5):411-3. PubMed ID: 18718534
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preface for special issue on enzyme engineering].
    Jin C
    Sheng Wu Gong Cheng Xue Bao; 2009 Dec; 25(12):1761-4. PubMed ID: 20352948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Friends or Foes? Emerging Impacts of Biological Toxins.
    Clark GC; Casewell NR; Elliott CT; Harvey AL; Jamieson AG; Strong PN; Turner AD
    Trends Biochem Sci; 2019 Apr; 44(4):365-379. PubMed ID: 30651181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical aspects of toxin weapons.
    Bigalke H; Rummel A
    Toxicology; 2005 Oct; 214(3):210-20. PubMed ID: 16087285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel protein scaffolds as emerging therapeutic proteins: from discovery to clinical proof-of-concept.
    Wurch T; Pierré A; Depil S
    Trends Biotechnol; 2012 Nov; 30(11):575-82. PubMed ID: 22944617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preface for special issue on biological products].
    Liu W
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):671-4. PubMed ID: 21845831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction to the toxins special issue on plant toxins.
    Tumer NE
    Toxins (Basel); 2015 Nov; 7(11):4503-6. PubMed ID: 26837094
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody Engineering--IBC's 17th annual international conference. Antibody engineering and immunotherapeutics for the 21st century.
    Bradbury A
    IDrugs; 2007 Mar; 10(3):169-72. PubMed ID: 17351868
    [No Abstract]   [Full Text] [Related]  

  • 14. Special issue on «Toxins: from threats to benefits».
    Martin-Eauclaire MF; Benoit E; Marchot P; Barbier J; Molgó J; Servent D
    Toxicon; 2013 Dec; 75():1-2. PubMed ID: 23927926
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of peptidic toxins in the pharmacological approach of the diversity of calcium channels].
    Morel JL; Hugues M
    C R Seances Soc Biol Fil; 1998; 192(3):549-66. PubMed ID: 9759387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manufacturing of recombinant therapeutic proteins in microbial systems.
    Graumann K; Premstaller A
    Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies and genetically engineered related molecules: production and purification.
    Roque AC; Lowe CR; Taipa MA
    Biotechnol Prog; 2004; 20(3):639-54. PubMed ID: 15176864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-toxin hybrids: a clinical review of their use.
    Frankel AE
    J Biol Response Mod; 1985 Oct; 4(5):437-46. PubMed ID: 3935755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of venom peptides.
    Lewis RJ; Garcia ML
    Nat Rev Drug Discov; 2003 Oct; 2(10):790-802. PubMed ID: 14526382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partitioning of model toxins to hydrophobically terminated DAB dendrimers.
    King M; Duan X; Sheardown H
    Biotechnol Bioeng; 2004 Jun; 86(5):512-9. PubMed ID: 15129434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.